In reviewHealthcare9 July 2025

KKR to acquire KARO HEALTHCARE

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

KKR acquires KARO HEALTHCARE

Deal facts

Buyer
KKR
Target
KARO HEALTHCARE
Deal value
Not disclosed
Announced
9 July 2025
Status
In review
Sector
Healthcare
Country
Not stated
Consideration
Not stated

Sources

What we know

KKR has agreed to acquire KARO HEALTHCARE in a private equity acquisition. The transaction was announced on 9 July 2025. The target operates within the NaceV2Sector_N_72.1 and NaceV2Sector_C_21 sectors. No specific deal value or consideration type has been disclosed in the available records. The target country is not reported in the current data set.

The transaction remains in the review stage as of the latest update. Regulatory approval is required before the deal can proceed to completion. The completion date has not yet been confirmed or announced to the public. Further details regarding the specific terms of the agreement are not currently available for review. This summary reflects the facts provided in the source data without additional speculation.

Weekly digest

Join Exit Mode Insider

Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.

Join Exit Mode Insider, £12/mo

Deal timeline

1 update
  1. CMA invitation to comment

    KKR to acquire KARO HEALTHCARE

    KKR to acquire KARO HEALTHCARE

    EU DG COMP

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

Buyer history

KKR

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive